Sage Journals: Discover world-class research

Abstract

Italian

Introduction

Sepsis is one of the main causes of death in critically ill patients worldwide, and in many cases it is associated with renal and/or other organ failure. However, we do not have an efficient therapy to reduce its extremely high mortality rate. In the last years the interest around the use of extracorporeal blood purification techniques has increased. One of the emerging treatments in patients with severe sepsis and septic shock is coupled plasma filtration adsorption (CPFA). CPFA is a novel extracorporeal blood purification therapy aimed at non-selectively reducing the circulating levels and activities of both pro and anti-inflammatory mediators. The aim of this study, conducted in septic patients, was to observe the effects of CPFA on mortality and several laboratory and hemodynamic parameters.

Patients and Methods

We treated 65 patients (50 males and 15 females) with CPFA. We then analysed the mean arterial pressure (MAP), the sequential organ failure assessment (SOFA) score, and the acute physiology and chronic health evaluation II (APACHE II) score. Serum levels of interleukin-6 and procalcitonin were also measured.

Results

After 28 days we observed a mortality of 36.9% (24 patients) and a significant reduction in IL-6, procalcitonin, SOFA and APACHE scores.

Conclusion

CPFA represents a promising new approach for blood purification in sepsis.

Keywords

CPFA Sepsis Procalcitonin Interleukin-6 Sepsi Procalcitonina Interleuchina-6

Get full access to this article

View all access options for this article.

References

Ronco

, Bellomo

. Acute renal failure and multiple organ dysfunction in the ICU from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 25: 733–47.

Nalesso

. Trattamento extracorporeo dell'insufficienza reale acuta (AKI) durante la Sepsi. G Ital Nefrol 2012; 29(Suppl 56): 535–40.

Tetta

. L'aferesi in rianimazione in L'aferesi terapeutica, Editoriale Bios 2002; 105–10.

Ronco

. Terapie extracorporee speciali in L'aferesi terapeutica, Editoriale Bios 2005; 23–32.

Splendiani

, Stuart

. Techniche depurative nelle patologie extrarenali in La dialisi Tecnica e clinica, S.E.U. 2007; 106–15.

Ferrannini

, Vischini

, Staffolani

. Rheopheresis in vascular diseases. Int J Artif Organs 2007; 30(10): 923–9.

Bosch

. Recent advances in therapeutic apheresis. J Artif Organs 2003; 6(1): 1–8.

Cohen

. The immunopathogenesis of sepsis. Nature 2002; 420(6917): 885–91.

Mokart

, Merlin

, Sannini

. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaest 2005; 94(6): 767–73.

10.

Bellomo

, Honoré

P.M.

, Matson

, Ronco

, Winchester

. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 2005; 28(5): 450–8.

11.

Bellomo

, Tetta

, Ronco

. Coupled plasma filtration adsorption. Intensive Care Med 2003; 29(8): 1222–8.

12.

Turani

, Falco

, Barchetta

. different effect of CVVHDF and coupled plasma filtration and adsorption on IL-6 and procalcitonin in sepsis. Critical Care 2011; 15(Suppl 1): S42.

13.

GiViTI.

Le infezioni in terapia intensiva. Rapporto del progetto di sorveglianza del GiViTI, anno 2005.

Ricerca e Pratica 2007; 23: 148–59.